Yeah fair enough. I was just pointing out the fact that, according to the research by Husch Blackwell, a type A meeting is not a formal response to the CRL by MSB. According the document a “hearing” which is “open and public” is the only way to formly respond to the CRL if MSB choose not to resubmit or withdraw the application.
MSB to dispute FDA finding in Type A meeting, page-424
-
- There are more pages in this discussion • 594 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |